ZYBT

Today, 4:06 AMProfit-taking drives 60% ZYBT premarket plunge after newsless 1000% surge

Peers: INCR ANIK LFCR TKNO DERM OGI ASRT CRDL OPTH ACB

Index	-
Market Cap	121.87M
Enterprise Value	133.32M
Income	-9.74M
Sales	16.18M
Book/sh	0.75
Cash/sh	0.25
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	269
IPO	Jan 07, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	7.53
P/B	5.43
P/C	16.40
P/FCF	70.45
EV/EBITDA	-
EV/Sales	8.24
Quick Ratio	0.80
Current Ratio	1.14
Debt/Eq	0.30
LT Debt/Eq	0.04
Option/Short	No / No

EPS (ttm)	-0.21
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	-25.18% -16.43%
EPS Y/Y TTM	-717.42%
Sales Y/Y TTM	-37.53%
EPS Q/Q	-2195.59%
Sales Q/Q	-40.44%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	74.06%
Insider Trans	0.00%
Inst Own	0.41%
Inst Trans	-24.93%
ROA	-14.98%
ROE	-26.09%
ROIC	-26.28%
Gross Margin	20.41%
Oper. Margin	-60.73%
Profit Margin	-60.22%
SMA20	224.94%
SMA50	300.12%
SMA200	200.64%
Trades

Shs Outstand	29.73M
Shs Float	7.71M
Short Float	0.56%
Short Ratio	0.02
Short Interest	0.04M
52W High	13.08 -68.65%
52W Low	0.62 566.13%
Volatility	119.49% 36.26%
ATR (14)	0.99
RSI (14)	62.76
Beta	-10.37
Rel Volume	121.98
Avg Volume	2.78M
Volume	16,946,899

Perf Week	477.06%
Perf Month	446.67%
Perf Quarter	331.58%
Perf Half Y	272.73%
Perf YTD	256.52%
Perf Year	-27.94%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	8.01
Price	4.10
Change	-48.81%

Jun-04-26 04:05PM	Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Apr-28-26 04:30PM	Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results (PR Newswire) -5.69%
Apr-06-26 09:25AM	Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure (GlobeNewswire)
Feb-10-26 08:30AM	Zhengye Biotechnology Holding Limited Issues 2026 Chairman's Letter to Shareholders (GlobeNewswire)
Jul-03-25 08:30AM	Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results (PR Newswire)
04:05PM	Loading…
May-23-25 04:05PM	Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F (GlobeNewswire) -12.33%
Jan-14-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option (GlobeNewswire)
Jan-08-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering (GlobeNewswire) -7.41%
Jan-06-25 05:50PM	Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering (GlobeNewswire)

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.

Co-Chief Executive OfficerMr. Songlin Song

Chief Financial OfficerMr. Ping Wang

Chief Operating OfficerMr. Zhongyao Liu

Vice General ManagerMs. Yuhong Cheng

Co-Chief Executive OfficerMr. Aiden Han

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vanguards Skyline Holdings Lim	Shareholder	Nov 01 '25	Proposed Sale	12.91	2,278,752	29,419,666		Oct 22 04:10 PM
VVAX Holdings Limited	Shareholder	Nov 01 '25	Proposed Sale	2.62	684,996	1,794,690		Oct 22 04:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Zhengye Biotechnology Holding Ltd

Upgrade your Finviz experience